Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
AME vs PNR vs DHR vs ROP vs A
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Medical - Diagnostics & Research
Industrial - Machinery
Medical - Diagnostics & Research
AME vs PNR vs DHR vs ROP vs A — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Medical - Diagnostics & Research | Industrial - Machinery | Medical - Diagnostics & Research |
| Market Cap | $53.72B | $12.76B | $124.33B | $36.28B | $33.58B |
| Revenue (TTM) | $7.60B | $4.20B | $24.78B | $8.12B | $7.07B |
| Net Income (TTM) | $1.53B | $671M | $3.69B | $1.71B | $1.29B |
| Gross Margin | 36.6% | 40.9% | 60.7% | 69.4% | 38.8% |
| Operating Margin | 26.2% | 20.6% | 21.0% | 28.1% | 20.6% |
| Forward P/E | 29.1x | 14.8x | 20.8x | 16.1x | 19.9x |
| Total Debt | $2.28B | $1.64B | $18.42B | $9.30B | $3.35B |
| Cash & Equiv. | $458M | $102M | $4.62B | $297M | $1.79B |
AME vs PNR vs DHR vs ROP vs A — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMETEK, Inc. (AME) | 100 | 255.7 | +155.7% |
| Pentair plc (PNR) | 100 | 201.8 | +101.8% |
| Danaher Corporation (DHR) | 100 | 118.9 | +18.9% |
| Roper Technologies,… (ROP) | 100 | 89.5 | -10.5% |
| Agilent Technologie… (A) | 100 | 134.6 | +34.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AME vs PNR vs DHR vs ROP vs A
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AME is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 423.4% 10Y total return vs A's 205.7%
- Lower volatility, beta 0.93, Low D/E 21.5%, current ratio 1.06x
- 0.5% yield, 16-year raise streak, vs PNR's 1.3%
- +38.9% vs ROP's -38.0%
PNR ranks third and is worth considering specifically for valuation efficiency.
- PEG 1.13 vs DHR's 34.35
- Lower P/E (14.8x vs 19.9x), PEG 1.13 vs 1.35
Among these 5 stocks, DHR doesn't own a clear edge in any measured category.
ROP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 0.43, yield 0.9%
- Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
- Beta 0.43, yield 0.9%, current ratio 0.52x
- 12.3% revenue growth vs PNR's 2.3%
A is the clearest fit if your priority is efficiency.
- 10.1% ROA vs DHR's 4.5%, ROIC 13.5% vs 5.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs PNR's 2.3% | |
| Value | Lower P/E (14.8x vs 19.9x), PEG 1.13 vs 1.35 | |
| Quality / Margins | 21.1% margin vs DHR's 14.9% | |
| Stability / Safety | Beta 0.43 vs A's 1.23, lower leverage | |
| Dividends | 0.5% yield, 16-year raise streak, vs PNR's 1.3% | |
| Momentum (1Y) | +38.9% vs ROP's -38.0% | |
| Efficiency (ROA) | 10.1% ROA vs DHR's 4.5%, ROIC 13.5% vs 5.9% |
AME vs PNR vs DHR vs ROP vs A — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AME vs PNR vs DHR vs ROP vs A — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 1 of 6 categories
PNR leads 1 • AME leads 1 • DHR leads 0 • A leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 5.9x PNR's $4.2B. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to DHR's 14.9%. On growth, AME holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.6B | $4.2B | $24.8B | $8.1B | $7.1B |
| EBITDAEarnings before interest/tax | $2.3B | $983M | $7.2B | $3.2B | $1.7B |
| Net IncomeAfter-tax profit | $1.5B | $671M | $3.7B | $1.7B | $1.3B |
| Free Cash FlowCash after capex | $1.7B | $716M | $5.3B | $2.6B | $993M |
| Gross MarginGross profit ÷ Revenue | +36.6% | +40.9% | +60.7% | +69.4% | +38.8% |
| Operating MarginEBIT ÷ Revenue | +26.2% | +20.6% | +21.0% | +28.1% | +20.6% |
| Net MarginNet income ÷ Revenue | +20.1% | +16.0% | +14.9% | +21.1% | +18.3% |
| FCF MarginFCF ÷ Revenue | +22.4% | +17.0% | +21.4% | +31.4% | +14.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.3% | +2.6% | +3.7% | +11.3% | +7.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.5% | +12.9% | +9.8% | +59.1% | -3.6% |
Valuation Metrics
PNR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 19.9x trailing earnings, PNR trades at a 46% valuation discount to AME's 36.6x P/E. Adjusting for growth (PEG ratio), PNR offers better value at 1.52x vs DHR's 34.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $53.7B | $12.8B | $124.3B | $36.3B | $33.6B |
| Enterprise ValueMkt cap + debt − cash | $55.5B | $14.3B | $138.1B | $45.3B | $35.1B |
| Trailing P/EPrice ÷ TTM EPS | 36.64x | 19.94x | 34.85x | 24.82x | 25.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.08x | 14.75x | 20.82x | 16.08x | 19.87x |
| PEG RatioP/E ÷ EPS growth rate | 3.28x | 1.52x | 34.35x | 2.59x | 1.76x |
| EV / EBITDAEnterprise value multiple | 29.55x | 14.66x | 18.21x | 14.57x | 19.89x |
| Price / SalesMarket cap ÷ Revenue | 7.26x | 3.06x | 5.06x | 4.59x | 4.83x |
| Price / BookPrice ÷ Book value/share | 5.10x | 3.38x | 2.38x | 1.91x | 5.00x |
| Price / FCFMarket cap ÷ FCF | 32.14x | 17.11x | 23.64x | 14.55x | 29.15x |
Profitability & Efficiency
Evenly matched — AME and PNR and A each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $7 for DHR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to A's 0.50x. On the Piotroski fundamental quality scale (0–9), PNR scores 8/9 vs A's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.4% | +17.7% | +7.1% | +8.8% | +18.7% |
| ROA (TTM)Return on assets | +9.6% | +9.9% | +4.5% | +5.0% | +10.1% |
| ROICReturn on invested capital | +12.1% | +12.1% | +5.9% | +6.1% | +13.5% |
| ROCEReturn on capital employed | +15.0% | +15.0% | +7.0% | +7.7% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.21x | 0.42x | 0.35x | 0.47x | 0.50x |
| Net DebtTotal debt minus cash | $1.8B | $1.5B | $13.8B | $9.0B | $1.6B |
| Cash & Equiv.Liquid assets | $458M | $102M | $4.6B | $297M | $1.8B |
| Total DebtShort + long-term debt | $2.3B | $1.6B | $18.4B | $9.3B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | 23.34x | 11.94x | 18.13x | 6.50x | 19.53x |
Total Returns (Dividends Reinvested)
AME leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AME five years ago would be worth $17,454 today (with dividends reinvested), compared to $7,893 for DHR. Over the past 12 months, AME leads with a +38.9% total return vs ROP's -38.0%. The 3-year compound annual growth rate (CAGR) favors AME at 18.0% vs ROP's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.3% | -24.6% | -23.6% | -18.5% | -13.6% |
| 1-Year ReturnPast 12 months | +38.9% | -12.8% | -8.3% | -38.0% | +11.3% |
| 3-Year ReturnCumulative with dividends | +64.1% | +39.8% | -15.5% | -21.0% | -8.2% |
| 5-Year ReturnCumulative with dividends | +74.5% | +23.0% | -21.1% | -17.5% | -8.0% |
| 10-Year ReturnCumulative with dividends | +423.4% | +126.9% | +219.3% | +115.0% | +205.7% |
| CAGR (3Y)Annualised 3-year return | +18.0% | +11.8% | -5.5% | -7.6% | -2.8% |
Risk & Volatility
Evenly matched — AME and ROP each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than A's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 96.4% from its 52-week high vs ROP's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.93x | 1.22x | 0.94x | 0.43x | 1.23x |
| 52-Week HighHighest price in past year | $243.18 | $113.95 | $242.80 | $584.03 | $160.27 |
| 52-Week LowLowest price in past year | $168.49 | $77.02 | $172.06 | $313.86 | $104.79 |
| % of 52W HighCurrent price vs 52-week peak | +96.4% | +69.3% | +72.3% | +60.3% | +74.0% |
| RSI (14)Momentum oscillator 0–100 | 63.3 | 35.3 | 33.0 | 43.6 | 52.5 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 1.6M | 4.2M | 1.2M | 2.0M |
Analyst Outlook
Evenly matched — AME and PNR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AME as "Buy", PNR as "Hold", DHR as "Buy", ROP as "Buy", A as "Buy". Consensus price targets imply 43.8% upside for PNR (target: $114) vs 4.9% for AME (target: $246). For income investors, PNR offers the higher dividend yield at 1.26% vs AME's 0.53%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $245.91 | $113.56 | $247.00 | $457.64 | $166.00 |
| # AnalystsCovering analysts | 29 | 41 | 42 | 23 | 38 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.3% | +0.7% | +0.9% | +0.8% |
| Dividend StreakConsecutive years of raises | 16 | 6 | 1 | 12 | 10 |
| Dividend / ShareAnnual DPS | $1.23 | $0.99 | $1.23 | $3.29 | $0.99 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +1.8% | +2.5% | +1.4% | +1.3% |
ROP leads in 1 of 6 categories (Income & Cash Flow). PNR leads in 1 (Valuation Metrics). 3 tied.
AME vs PNR vs DHR vs ROP vs A: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AME or PNR or DHR or ROP or A a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 2. 3% for Pentair plc (PNR). Pentair plc (PNR) offers the better valuation at 19. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate AMETEK, Inc. (AME) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AME or PNR or DHR or ROP or A?
On trailing P/E, Pentair plc (PNR) is the cheapest at 19.
9x versus AMETEK, Inc. at 36. 6x. On forward P/E, Pentair plc is actually cheaper at 14. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Pentair plc wins at 1. 13x versus Danaher Corporation's 34. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AME or PNR or DHR or ROP or A?
Over the past 5 years, AMETEK, Inc.
(AME) delivered a total return of +74. 5%, compared to -21. 1% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: AME returned +423. 4% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AME or PNR or DHR or ROP or A?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 43β versus Agilent Technologies, Inc. 's 1. 23β — meaning A is approximately 188% more volatile than ROP relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 50% for Agilent Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AME or PNR or DHR or ROP or A?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 2. 3% for Pentair plc (PNR). On earnings-per-share growth, the picture is similar: AMETEK, Inc. grew EPS 7. 9% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, ROP leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AME or PNR or DHR or ROP or A?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 20. 5% for PNR. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AME or PNR or DHR or ROP or A more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Pentair plc (PNR) is the more undervalued stock at a PEG of 1. 13x versus Danaher Corporation's 34. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Pentair plc (PNR) trades at 14. 8x forward P/E versus 29. 1x for AMETEK, Inc. — 14. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PNR: 43. 8% to $113. 56.
08Which pays a better dividend — AME or PNR or DHR or ROP or A?
All stocks in this comparison pay dividends.
Pentair plc (PNR) offers the highest yield at 1. 3%, versus 0. 5% for AMETEK, Inc. (AME).
09Is AME or PNR or DHR or ROP or A better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 0. 9% yield, +115. 0% 10Y return). Both have compounded well over 10 years (ROP: +115. 0%, PNR: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AME and PNR and DHR and ROP and A?
These companies operate in different sectors (AME (Industrials) and PNR (Industrials) and DHR (Healthcare) and ROP (Industrials) and A (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.